top of page

Reproductive & Endocrine Systems

Diabetes mellitus (type 1 vs type 2) pathophysiology

Core Principle of Diabetes Mellitus Pathophysiology
🧷 Diabetes mellitus is fundamentally a disorder of insulin action — either absolute deficiency (type 1) or relative deficiency with resistance (type 2) — leading to hyperglycemia and metabolic derangements.
🧷 Type 1 results from autoimmune β-cell destruction in the pancreatic islets, causing complete insulin deficiency and dependence on exogenous insulin for survival.
🧷 Type 2 results from peripheral insulin resistance combined with progressive β-cell dysfunction, creating a relative insulin deficiency despite often elevated insulin levels.
🧷 Both types share the downstream consequences of hyperglycemia: osmotic diuresis, microvascular complications, and macrovascular disease.
Solid White Background
Type 1 Diabetes: Autoimmune β-Cell Destruction
📍 T-cell mediated destruction of pancreatic β-cells occurs over months to years, with 80–90% of β-cell mass lost before clinical presentation.
📍 Autoantibodies serve as markers of autoimmunity: anti-GAD65, anti-insulin, anti-IA2, and anti-ZnT8 — though they are not the direct mediators of destruction.
📍 Genetic susceptibility involves HLA-DR3 and HLA-DR4 haplotypes, with highest risk in DR3/DR4 heterozygotes.
📍 Environmental triggers remain poorly defined but may include viral infections (Coxsackie B, enteroviruses) or early dietary exposures.
📍 Board pearl: Presence of ≥2 autoantibodies in a first-degree relative indicates >90% lifetime risk of developing type 1 diabetes.
Solid White Background
Type 2 Diabetes: Insulin Resistance and β-Cell Dysfunction
🔹 Insulin resistance begins in muscle and adipose tissue — cells fail to respond normally to insulin, requiring higher insulin levels to maintain normoglycemia.
🔹 Initially, β-cells compensate by increasing insulin secretion (hyperinsulinemia), maintaining normal glucose levels despite resistance.
🔹 Over time, β-cells fail to maintain this compensatory response — insulin secretion becomes insufficient relative to demand, and hyperglycemia develops.
🔹 This β-cell exhaustion involves glucotoxicity, lipotoxicity, amyloid deposition, and oxidative stress.
🔹 Board pearl: The hallmark of type 2 diabetes progression is the transition from hyperinsulinemia with normoglycemia to relative hypoinsulinemia with hyperglycemia.
Solid White Background
Molecular Mechanisms of Insulin Resistance
⭐ Insulin normally binds its receptor → autophosphorylation → IRS-1/2 phosphorylation → PI3K activation → Akt activation → GLUT4 translocation to cell surface.
⭐ In insulin resistance, this signaling cascade is impaired at multiple levels: decreased receptor number, impaired autophosphorylation, increased IRS-1 serine phosphorylation (inhibitory), and defective GLUT4 translocation.
⭐ Free fatty acids, inflammatory cytokines (TNF-α, IL-6), and adipokines contribute to signaling defects.
⭐ Ectopic lipid accumulation in muscle and liver creates lipotoxicity, further impairing insulin signaling.
⭐ Board distinction: Type 2 diabetes involves post-receptor defects in insulin signaling, while rare genetic forms involve receptor mutations.
Solid White Background
Metabolic Syndrome and Type 2 Diabetes Risk
✅ Metabolic syndrome represents a cluster of insulin resistance manifestations: central obesity, hypertension, dyslipidemia (↑ triglycerides, ↓ HDL), and impaired fasting glucose.
✅ Visceral adiposity drives systemic inflammation through adipocytokine dysregulation: ↑ leptin, ↓ adiponectin, ↑ resistin, ↑ inflammatory cytokines.
✅ These adipocytokines directly impair insulin signaling and promote hepatic gluconeogenesis.
✅ The syndrome dramatically increases type 2 diabetes risk — present in >80% of patients at diagnosis.
✅ Board pearl: Acanthosis nigricans (velvety hyperpigmentation in skin folds) is a cutaneous marker of insulin resistance, not just obesity.
Solid White Background
Hepatic Glucose Production in Diabetes
🧠 In the fasted state, the liver maintains blood glucose through gluconeogenesis and glycogenolysis — normally suppressed by insulin.
🧠 Type 1 diabetes: absent insulin → unrestrained hepatic glucose output → fasting hyperglycemia.
🧠 Type 2 diabetes: hepatic insulin resistance → failure to suppress gluconeogenesis despite hyperinsulinemia → elevated fasting glucose.
🧠 Key gluconeogenic enzymes (PEPCK, G6Pase) remain active inappropriately, driven by glucagon excess relative to insulin action.
🧠 Board pearl: Metformin's primary mechanism is suppression of hepatic gluconeogenesis, explaining its effectiveness for fasting hyperglycemia.
Solid White Background
Glucose Uptake Defects in Peripheral Tissues
⚡ Muscle accounts for ~80% of insulin-stimulated glucose disposal — the primary site of postprandial glucose uptake.
⚡ In insulin resistance, GLUT4 translocation to the muscle cell surface is impaired → decreased glucose uptake despite hyperglycemia and hyperinsulinemia.
⚡ Adipose tissue shows similar GLUT4 translocation defects, though its contribution to total glucose disposal is smaller.
⚡ The result is postprandial hyperglycemia as ingested glucose cannot be effectively cleared from circulation.
⚡ Board pearl: Exercise promotes GLUT4 translocation through insulin-independent pathways (AMPK activation), explaining its glucose-lowering effect.
Solid White Background
β-Cell Dysfunction Progression
📌 Normal β-cells sense glucose through glucokinase → ATP generation → K⁺ channel closure → depolarization → Ca²⁺ influx → insulin vesicle exocytosis.
📌 First-phase insulin release (immediate spike) is lost early in type 2 diabetes, indicating β-cell dysfunction even before overt hyperglycemia.
📌 Chronic hyperglycemia creates glucotoxicity: oxidative stress, ER stress, mitochondrial dysfunction, and impaired insulin gene transcription.
📌 Islet amyloid polypeptide (IAPP/amylin) co-secreted with insulin forms toxic oligomers and amyloid deposits, contributing to β-cell death.
📌 Board pearl: Loss of first-phase insulin secretion is the earliest detectable β-cell abnormality in type 2 diabetes progression.
Solid White Background
Lipotoxicity and Free Fatty Acids
📣 Elevated free fatty acids (FFAs) are both a cause and consequence of insulin resistance, creating a vicious cycle.
📣 In adipose tissue, insulin resistance → impaired suppression of lipolysis → increased FFA release into circulation.
📣 FFAs impair insulin signaling in muscle through PKC activation and IRS-1 serine phosphorylation.
📣 In β-cells, chronic FFA exposure causes lipotoxicity: impaired insulin secretion, increased apoptosis, and reduced β-cell mass.
📣 Board pearl: The combination of glucotoxicity and lipotoxicity accelerates β-cell failure — explaining why tight glycemic and lipid control preserves β-cell function.
Solid White Background
Inflammatory Pathways in Type 2 Diabetes
🔸 Obesity induces chronic low-grade inflammation in adipose tissue: macrophage infiltration, shift from M2 (anti-inflammatory) to M1 (pro-inflammatory) phenotype.
🔸 Inflammatory cytokines (TNF-α, IL-6, IL-1β) directly impair insulin signaling through JNK and IKKβ pathway activation.
🔸 These pathways increase IRS-1 serine phosphorylation (inhibitory) and decrease tyrosine phosphorylation (activating).
🔸 Systemic markers of inflammation (CRP, fibrinogen) are elevated and predict type 2 diabetes development.
🔸 Board pearl: The link between inflammation and insulin resistance explains why anti-inflammatory interventions (weight loss, exercise) improve glycemic control.
Solid White Background
Genetics of Type 1 vs Type 2 Diabetes
🧷 Type 1: Strong HLA association (50% of genetic risk), with specific alleles conferring susceptibility (DR3/DR4) or protection (DQB1*0602).
🧷 Type 1: Non-HLA genes contribute smaller effects: INS-VNTR, PTPN22, CTLA4, IL2RA — mostly immune regulation genes.
🧷 Type 2: Polygenic with >400 identified risk loci, each contributing small effects — most affect β-cell function rather than insulin action.
🧷 Type 2: TCF7L2 is the strongest common variant, affecting incretin signaling and β-cell function.
🧷 Board distinction: Type 1 shows strong HLA association and lower concordance in monozygotic twins (~50%), while type 2 shows no HLA association and higher twin concordance (~90%).
Solid White Background
Incretin Dysfunction in Type 2 Diabetes
📍 Incretins (GLP-1 and GIP) are gut hormones that augment insulin secretion in response to oral glucose — accounting for 50–70% of total insulin secretion.
📍 The incretin effect is markedly reduced in type 2 diabetes: impaired GLP-1 secretion and β-cell resistance to GIP.
📍 This explains why oral glucose causes higher insulin secretion than IV glucose in healthy individuals but not in type 2 diabetes.
📍 DPP-4 rapidly degrades incretins; its inhibition or use of DPP-4-resistant GLP-1 analogs restores incretin action.
📍 Board pearl: The loss of incretin effect explains why postprandial hyperglycemia occurs early in type 2 diabetes despite preserved fasting glucose.
Solid White Background
Glucagon Dysregulation in Diabetes
🔹 Normal physiology: glucagon rises during fasting to maintain glucose; insulin suppresses glucagon during fed state.
🔹 Type 1 diabetes: loss of paracrine insulin from β-cells → unsuppressed α-cell glucagon secretion → inappropriate hepatic glucose output.
🔹 Type 2 diabetes: α-cell insulin resistance → failure to suppress glucagon postprandially → persistent hepatic glucose production despite hyperglycemia.
🔹 Later in type 1: α-cell dysfunction develops → impaired glucagon response to hypoglycemia → increased hypoglycemia risk.
🔹 Board pearl: Paradoxical glucagon elevation after meals is a hallmark of both diabetes types but through different mechanisms.
Solid White Background
Renal Glucose Handling in Diabetes
⭐ The kidney filters ~180g glucose daily, with >99% reabsorbed by SGLT2 (90%) and SGLT1 (10%) in the proximal tubule.
⭐ Reabsorption has a transport maximum (Tm) — when exceeded, glucosuria occurs. Normal threshold is ~180 mg/dL.
⭐ In diabetes, SGLT2 expression increases → higher reabsorption capacity → less glucosuria than expected for degree of hyperglycemia.
⭐ This maladaptive response perpetuates hyperglycemia by preventing urinary glucose loss.
⭐ Board pearl: SGLT2 inhibitors exploit this physiology by blocking reabsorption, causing intentional glucosuria and lowering blood glucose.
Solid White Background
Dawn Phenomenon and Somogyi Effect
✅ Dawn phenomenon: early morning hyperglycemia due to overnight growth hormone and cortisol surge → increased hepatic glucose output without preceding hypoglycemia.
✅ Somogyi effect: rebound hyperglycemia following nocturnal hypoglycemia due to counter-regulatory hormone release (glucagon, epinephrine, cortisol).
✅ Distinguished by 3 AM glucose check: normal/high in dawn phenomenon, low in Somogyi effect.
✅ Dawn phenomenon is common in both diabetes types; Somogyi effect primarily occurs with insulin therapy.
✅ Board distinction: Dawn phenomenon requires increased basal insulin; Somogyi effect requires decreased evening insulin.
Solid White Background
Honeymoon Phase in Type 1 Diabetes
🧠 Following diagnosis and insulin initiation, many type 1 patients experience temporary partial remission — the "honeymoon phase."
🧠 Mechanism: glucose normalization relieves glucotoxicity on remaining β-cells → improved endogenous insulin secretion → reduced exogenous insulin requirements.
🧠 Typically lasts weeks to months, rarely exceeding two years.
🧠 C-peptide remains detectable during this phase but eventually becomes undetectable as β-cell destruction completes.
🧠 Board pearl: Honeymoon phase does not indicate misdiagnosis or cure — insulin requirements will inevitably increase as remaining β-cells are destroyed.
Solid White Background
Diabetic Ketoacidosis vs Hyperosmolar Hyperglycemic State
⚡ DKA (mainly type 1): absolute insulin deficiency → unrestrained lipolysis → ketogenesis → anion gap metabolic acidosis with glucose typically 250–600 mg/dL.
⚡ HHS (mainly type 2): relative insulin deficiency with enough insulin to prevent ketosis but not hyperglycemia → glucose often >600 mg/dL with hyperosmolarity.
⚡ DKA develops over hours to days; HHS develops over days to weeks with severe dehydration.
⚡ Key difference: insulin levels sufficient to suppress lipolysis in HHS but not in DKA.
⚡ Board pearl: Presence of measurable C-peptide during hyperglycemic crisis suggests type 2 diabetes with HHS rather than type 1 with DKA.
Solid White Background
Maturity-Onset Diabetes of the Young (MODY)
📌 MODY represents monogenic diabetes due to single gene defects affecting β-cell function — autosomal dominant inheritance.
📌 Presents before age 25 with non-insulin dependent diabetes, often misdiagnosed as type 1 or type 2.
📌 MODY2 (glucokinase): mild, stable hyperglycemia rarely requiring treatment.
📌 MODY3 (HNF1A): progressive hyperglycemia, extremely sensitive to sulfonylureas.
📌 MODY1 (HNF4A): similar to MODY3 plus neonatal hyperinsulinemic hypoglycemia.
📌 Board pearl: Young, non-obese patient with strong family history and negative autoantibodies → consider MODY genetic testing.
Solid White Background
Board Question Stem Patterns
📣 Child with polyuria, weight loss, and ketonuria → type 1 diabetes with DKA.
📣 Obese patient with acanthosis nigricans and family history → type 2 diabetes with insulin resistance.
📣 Normal weight patient with positive anti-GAD and low C-peptide → type 1 diabetes.
📣 Elderly patient with glucose >600 mg/dL, altered mental status, no ketones → hyperosmolar hyperglycemic state.
📣 Young adult with mild hyperglycemia and glucosuria at normal blood glucose → MODY2 (glucokinase mutation).
📣 Type 2 patient with worsening control despite oral agents → β-cell exhaustion requiring insulin.
📣 Morning hyperglycemia that improves with decreased evening insulin → Somogyi effect.
Solid White Background
One-Line Recap
🔸 Diabetes pathophysiology centers on insulin deficiency — absolute in type 1 (autoimmune β-cell destruction) versus relative in type 2 (peripheral resistance plus β-cell dysfunction) — leading to hyperglycemia through unsuppressed hepatic glucose output, impaired peripheral uptake, and progressive β-cell failure accelerated by glucotoxicity, lipotoxicity, and inflammation.
Solid White Background
bottom of page